T
Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on difficult-to-treat cancers, today announces that two abstracts highlighting real-world clinical outcomes for Pepaxti (melflufen) in relapsed, refractory multiple myeloma (RRMM) have been accepted for presentation at the 68th American Society of Hematology (ASH) Annual Meeting, taking place in New Orleans, USA, December 12–15, 2026.
T
MRM Health, a clinical-stage biotech developing microbiome-based therapies for immune-mediated diseases, and Biocodex, an independent French pharmaceutical company with more than 70 years of experience in the microbiome field, today announced the launch of a strategic partnership to establish specialized manufacturing capabilities for live biotherapeutic products.
T
Siemens Healthineers announced today it has initiated the carve-out process for its in vitro diagnostics business, marking an important step toward establishing a standalone company that will operate under the name Olyrian Diagnostics.
T
Evaxion A/S (“Evaxion”), a clinical-stage TechBio company developing novel immunotherapies with its pioneering AI-Immunology™ platform, will present new data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia (AML), in a poster session at the American Society of Hematology (ASH) Annual Meeting and Exposition in New Orleans, Louisiana, December 12-15, 2026.
T
In a new study in Nature Methods, researchers at the Centre for Genomic Regulation (CRG) in Barcelona describe a technique that looks only at the tRNAs on ribosomes busy making proteins.
T
Children who used a virtual reality (VR) headset before surgery showed reduced self-reported distress and fear, along with lower heart rate and blood pressure, according to a new study published November 5th in the open access journal PLOS Digital Health by Dayanjan Wijesinghe of Virginia Commonwealth University, US, and colleagues.
T
WashU Medicine researchers have verified the accuracy of genetics tools to correctly identify all the rare DNA changes that make up an individual's genomic mosaic, paving the way to understanding these variants' impact on health and disease.
T
Nail salon workers in New York City face greater health risks on the job than previously understood, according to a new study published in the journal Risk Analysis.
T
Researchers at Children's Hospital of Philadelphia (CHOP) found that a systematic, electronic health record-enabled quality improvement initiative was associated with a large increase in chlamydia and gonorrhea screening among adolescents and led to the detection of more infections.
T
A climate chamber, virtual environments and technology that monitors the body and brain. Using these resources, researchers at Umeå University will identify ways to protect older adults' mental well-being during heatwaves at home in northern Sweden.
T
Researchers analysing 285,444 adults in Finland and the UK found that excess mortality associated with extreme heat and cold was more than tenfold higher among people with both pre-existing medical conditions and socioeconomic disadvantage than among those with neither or only one vulnerability. Climate modelling suggested that warming from approximately 1°C to 4°C could increase the proportion of deaths attributable to extreme temperatures from around 1% to more than 5% in both countries.
T
Researchers at Roswell Park Comprehensive Cancer Center have identified a promising strategy for overcoming one of the biggest challenges facing KRAS-targeted cancer therapies: treatment resistance.
T
A $4 million grant from the National Institutes of Health is helping faculty researchers in the University of Virginia School of Engineering and Applied Science develop an artificial intelligence tool to personalize treatments for people with heart failure.
T
A breakthrough in the fight against mosquito-borne viruses could one day help protect patients from devastating neurological complications.
T
Pregnant patients receiving medication to treat opioid use disorder should not reduce their medication dose out of fear that it will worsen withdrawal symptoms in their newborns, according to a new study led by researchers at the University of Maryland School of Medicine (UMSOM).
T
A nanoscale particle with a unique structure, developed at MIT, holds potential as a customizable delivery vehicle for personalized cancer vaccines.
T
Researchers at the Max Delbrück Center and University Medical Center Hamburg-Eppendorf have traced in skin organoids, how herpes simplex virus 1 infection progresses among neighboring skin cells, deepening our understanding.
T
Fireside Project today announced the publication of "The Fireside Database: Large-Scale Evidence from 25,419 Psychedelic Support Interactions" in Science Advances, providing researchers and policymakers with an unprecedented empirical window into psychedelic use and support outside clinical settings.
T
Today, FAIR Health launches FAIR Health Atlas, a free epidemiological reporting platform incorporating data on the commercially insured population.
T
New research from Durham University highlights how insects have been part of human diets for thousands of years despite seeming unusual to many people.
T
The diagnosed prevalent cases of ulcerative colitis (UC) in the seven major markets (7 MM) are projected to reach over 2.36 million by 2035.
T
DEBRA Research gGmbH, a global non-profit organization dedicated to advancing research and drug development for Epidermolysis bullosa (EB), and Topadur Pharma AG, a Swiss clinical-stage biopharmaceutical company, today announced an investment by DEBRA Research in Topadur to support a preclinical program exploring a new treatment approach for dystrophic Epidermolysis bullosa (DEB). DEB is one of the more severe forms of EB, characterized by extremely fragile skin and progressive, debilitating…
T
Adalvo today announced the acquisition of a romiplostim biosimilar program referencing Nplate® from Enzene, strengthening its biosimilars portfolio and accelerating the company’s expansion into complex biological medicines.
T
Alcami, a leading contract development and manufacturing organization (CDMO), today announced its strengthening of laboratory leadership with the promotion of Robert Tragas to Vice President, Laboratory Services.
T
On the heels of our exciting major investment and Nantworks partnership announcement last week, Prolific Machines is pleased to announce a great new partnership with Zylidac Bio, a fully integrated biologics CDMO located next door to us in San Francisco Bay Area, to scale up the production of Prolific's Optogentics-enabled cell lines for clinical and GMP manufacturing!
T
NIOX Group plc, a global leader in fractional exhaled nitric oxide (FeNO) testing, has announced the launch of NIOX PRO®, its next-generation FeNO testing device designed to support healthcare professionals in the diagnosis and management of asthma, COPD and other inflammatory airway diseases.
T
Atelerix, a biotech company revolutionizing cell preservation and biological transport with its pioneering hydrogel encapsulation technology, today announced a partnership with Frontier Space, a UK based space biotechnology company building platform technology for in-orbit R&D and biomanufacturing.
T
It is a dietary staple found in sushi, rice wraps, and ramen toppings. Commonly known as nori in Japan and gim in Korea, red seaweed is especially popular across Asia.
T
The 2026 Report of the Lancet Countdown on Health and Climate Change finds that many of the health risks and harms of climate change grew faster in the decade since the Paris Agreement was introduced (2016–2025) than in the decade before it (2006–2015).
T
The first UK-wide analysis of bowel screening for patients with inflammatory bowel disease (IBD) has identified opportunities to improve the early detection of cancer.